These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 667235)

  • 1. CSF acid monoamine metabolites in psychotic syndromes: what might they signify?
    Bowers MB
    Biol Psychiatry; 1978 Jun; 13(3):375-83. PubMed ID: 667235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF amine metabolites, clinical symptoms, and body movement in psychiatric patients.
    Kirstein L; Bowers MB; Heninger G
    Biol Psychiatry; 1976 Aug; 11(4):421-34. PubMed ID: 963133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin (5HT) systems in psychotic states.
    Bowers MB
    Psychopharmacol Commun; 1975; 1(6):655-62. PubMed ID: 1224018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.
    Jennings WS; Schulz SC; Narasimhachari N; Hamer RM; Friedel RO
    Psychiatry Res; 1985 Oct; 16(2):87-94. PubMed ID: 2415997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients.
    Wode-Helgodt B; Fyrö B; Gullberg B; Sedvall G
    Acta Psychiatr Scand; 1977 Aug; 56(2):129-42. PubMed ID: 899844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history.
    Lindström LH
    Psychiatry Res; 1985 Apr; 14(4):265-73. PubMed ID: 2410940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines.
    Bowers MB
    Psychopharmacologia; 1973 Feb; 28(4):309-18. PubMed ID: 4572012
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.
    Ramirez-Bermudez J; Ruiz-Chow A; Perez-Neri I; Soto-Hernandez JL; Flores-Hernandez R; Nente F; Montes S; Rios C
    Gen Hosp Psychiatry; 2008; 30(4):337-43. PubMed ID: 18585537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
    Rüther E; Schilkrut R; Ackenheil M; Eben E; Hippius H
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):33-6. PubMed ID: 981320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
    Tang HZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes.
    Porta M; Bareggi SR; Collice M; Assael BM; Selenati A; Calderini G; Rossanda M; Morselli PL
    Eur Neurol; 1975; 13(6):545-54. PubMed ID: 1193101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers.
    Nybäck H; Berggren BM; Hindmarsh T; Sedvall G; Wiesel FA
    Psychiatry Res; 1983 Aug; 9(4):301-8. PubMed ID: 6196802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and somatosensory evoked potentials: I. Correlations between SEP and monoamine and purine metabolites in CSF.
    Agren H; Osterberg B; Niklasson F; Franzén O
    Biol Psychiatry; 1983 Jun; 18(6):635-49. PubMed ID: 6191784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.